Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.
Open | $0.42 |
Close | - |
Volume / Avg. | 211.80M / 985.17K |
Day Range | 0.40 - 0.66 |
52 Wk Range | 0.28 - 71.50 |
Market Cap | $3.23M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 4.53% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.
Other companies in Aptevo Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Exicure (NASDAQ:XCUR), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Entero Therapeutics (NASDAQ:ENTO).
There is no analysis for Aptevo Therapeutics.
Aptevo Therapeutics has a consensus price target of $20.00.
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $0.5677 last updated Today at July 17, 2024 at 10:57 AM EDT.
There are no upcoming dividends for Aptevo Therapeutics.
Aptevo Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Aptevo Therapeutics.
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.